caffeic acid phenethyl ester has been researched along with caffeic acid in 43 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (caffeic acid) | Trials (caffeic acid) | Recent Studies (post-2010) (caffeic acid) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 2,074 | 15 | 1,187 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | caffeic acid (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 23.7759 | |
| Lipoxygenase | Solanum tuberosum (potato) | 3.5 | |
| Interstitial collagenase | Homo sapiens (human) | 0.2389 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0243 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 8.5 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0156 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.06 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 3.37 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.1246 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3 | |
| Integrase | Human immunodeficiency virus 1 | 2.8 | |
| large T antigen | Betapolyomavirus macacae | 7.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 11 (25.58) | 29.6817 |
| 2010's | 21 (48.84) | 24.3611 |
| 2020's | 9 (20.93) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, S; Kataoka, S; Matsuda, H; Morikawa, T; Yoshikawa, M | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Imaizumi, T; Ishikawa, M; Kanno, S; Osanai, Y; Takeshita, M; Uwai, K | 1 |
| Hu, WX; Li, HB; Liu, F; Xia, CN | 1 |
| Antonini, G; Cechinel Filho, V; de Campos Buzzi, F; Fracasso, M; Franzoi, CL; Niero, R; Yunes, RA | 1 |
| Hashimoto, K; Hasumi, K; Koshino, H; Takahashi, S; Tani, H; Tatefuji, T | 1 |
| El-Kabbani, O; Endo, S; Hara, A; Hu, D; Ifuku, S; Li, J; Matsunaga, T; Ohta, S; Soda, M; Takemura, M; Toyooka, N; Wada, R; Yamamura, K; Zhao, HT | 1 |
| El-Kabbani, O; Endo, S; Hara, A; Kanamori, A; Matsunaga, T; Nagai, H; Ohta, S; Otsuji, Y; Sundaram, K; Toyooka, N | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Choi, HJ; Chung, TW; Ha, KT; Jeong, HS; Kim, CH; Lee, JY | 1 |
| Clabault, H; Hébert, MJ; Jean-François, J; Lassalle-Claux, G; Paré, AF; Patton, C; Sanderson, JT; Surette, ME; Touaibia, M | 1 |
| Kosaka, Y; Mizuguchi, M; Yokoyama, T | 1 |
| Cai, H; Huang, X; Huang, Y; Jiang, B; Jiang, J; Shen, H; Sun, Y; Wu, X; Xu, J; Xu, S; Yao, H; Zhang, P | 1 |
| Borges, F; Garrido, J; Martínez, A; Martínez-González, L; Mohamed, T; Pérez, DI; Rao, PP; Remião, F; Serrão, P; Shakeri, A; Silva, T; Soares-da-Silva, P; Uriarte, E; Valente, MJ | 1 |
| Byun, S; Kim, KH; Lee, E; Lee, SR; Shin, SH | 1 |
| Endo, Y; Hatayama, K; Hayashi, T; Nakano, H; Ohta, K; Sato, D; Sato, Y; Seki, C; Taguchi, R; Takahashi, T; Tokuraku, K; Uwai, K | 1 |
| Ahn, MR; Maruta, H | 1 |
| Borges, F; Mohamed, T; Rao, PPN; Remião, F; Shakeri, A; Silva, T; Soares da Silva, P | 1 |
| Hogan, L; Kim, MJ; Lassalle-Claux, G; Luiker, K; Murugesan, A; Reiman, T; Selka, A; Touaibia, M; Vaillancourt, E | 1 |
| Korshunova, GA; Mirzoeva, OK; Pushkareva, MA; Sud'ina, GF; Sumbatyan, NV; Varfolomeev, SD | 1 |
| Calder, PC; Mirzoeva, OK | 1 |
| Dworniczak, S; Pogorzelska, T; Rajca, M; Scheller, S; Shani, J | 1 |
| Hur, GM; Jin, C; Kim, YM; Lee, JY; Lee, YS; Park, EH; Ryu, YS; Song, YS | 1 |
| Chang, YC; Cho, G; Chung, TW; Kim, CH; Kim, JG; Kim, SH; Ko, JH; Lee, YC; Moon, SK | 1 |
| Celli, N; Dragani, LK; Murzilli, S; Pagliani, T; Poggi, A | 1 |
| Feng, Y; Li, W; Long, Y; Lu, YW; Wang, R; Wu, WM; Xu, PH | 1 |
| Bowman, PD; Bynum, JA; Kerwin, SM; Stavchansky, S; Wang, X; Zhao, B | 1 |
| Sojinu, OS; Tang, C | 1 |
| Chao, X; Chen, M; Huang, Y; Jin, M; Liu, A; Liu, J; Liu, P; Ouyang, Y; Pi, R; Qin, J; Ramassamy, C; Zhang, J | 1 |
| Cui, HS; Gu, SS; Wang, J; Wu, FA; Wu, XY | 1 |
| Jastrzębska-Stojko, Ż; Kabała-Dzik, A; Kubina, R; Rzepecka-Stojko, A; Stojko, J; Stojko, R; Wojtyczka, RD | 1 |
| Lohidasan, S; Mahadik, KR; Sadhana, N | 1 |
| Koo, YM; Mai, NL; Morya, VK; Rajapriya, G | 1 |
| Buszman, E; Kabała-Dzik, A; Kubina, R; Rzepecka-Stojko, A; Stojko, J; Wojtyczka, RD | 1 |
| Ahn, JH; Cho, AR; Sim, G; Song, MK | 1 |
| Novinec, M; Ulčakar, L | 1 |
| Qin, J; Wa, W; Wang, Y; Yang, M; Zheng, J | 1 |
| Belduz, AO; Guler, HI; Kolayli, S; Tatar, G; Yildiz, O | 1 |
| Adhikari, N; Shim, WS | 1 |
| Barnstable, CJ; Li, X; Ren, C; Tombran-Tink, J; Yu, Z; Zhang, M; Zhang, X; Zhou, P | 1 |
| Chen, Y; Kong, J; Li, M; Li, Y; Liu, J; Liu, M; Nai, X; Yan, H; Zhang, Q; Zhao, Z | 1 |
| Hagvall, L; Hurben, AK; Karlsson, I; Ndreu, L; Nyman, GSA; Tretyakova, NY | 1 |
| Basarslan, F; Basarslan, SK | 1 |
1 review(s) available for caffeic acid phenethyl ester and caffeic acid
| Article | Year |
|---|---|
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Topics: Animals; Antineoplastic Agents; Click Chemistry; Drug Discovery; Humans; Longevity; Neoplasms; p21-Activated Kinases; Protein Kinase Inhibitors | 2017 |
42 other study(ies) available for caffeic acid phenethyl ester and caffeic acid
| Article | Year |
|---|---|
Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.
Topics: Animals; Anti-Allergic Agents; Benzyl Alcohols; Carbon; Gastrointestinal Agents; Hydrogenation; Inhibitory Concentration 50; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Nitric Oxide; Phenylbutyrates; Phenylpropionates; Structure-Activity Relationship; Terpenes | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
Topics: Animals; Caffeic Acids; Cell Line; Cell Survival; Formazans; Lipopolysaccharides; Macrophages; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Nitric Oxide; Nitrites; Propolis; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Tetrazolium Salts | 2008 |
Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
Topics: Antineoplastic Agents; Binding Sites; Biotin; Caffeic Acids; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Enzyme-Linked Immunosorbent Assay; HIV Integrase; HIV Integrase Inhibitors; Humans; Inhibitory Concentration 50; Models, Chemical; Structure-Activity Relationship | 2008 |
Antinociceptive properties of caffeic acid derivatives in mice.
Topics: Analgesics; Animals; Caffeic Acids; Mice; Molecular Structure; Pain; Structure-Activity Relationship | 2009 |
Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes.
Topics: Animals; Anti-Allergic Agents; Bees; Cell Line, Tumor; Cysteine; Histamine; Humans; Leukocytes; Leukotrienes; Propolis; Rhinitis, Allergic, Seasonal | 2010 |
Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; Caffeic Acids; Catalytic Domain; Cell Survival; Enzyme Inhibitors; HeLa Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Propolis; Spectrophotometry, Infrared; Structure-Activity Relationship; U937 Cells | 2012 |
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Brazil; Crystallography, X-Ray; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Propolis; Stereoisomerism; Trichothecenes | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Caffeic acid phenethyl ester inhibits alpha-melanocyte stimulating hormone-induced melanin synthesis through suppressing transactivation activity of microphthalmia-associated transcription factor.
Topics: alpha-MSH; Animals; Blotting, Western; Caffeic Acids; Cyclic AMP Response Element-Binding Protein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Interferon Type I; Intramolecular Oxidoreductases; Levodopa; Melanins; Mice; Microphthalmia-Associated Transcription Factor; Molecular Structure; Monophenol Monooxygenase; Oxidoreductases; Phenylethyl Alcohol; Pregnancy Proteins; Transcriptional Activation | 2013 |
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Topics: Antineoplastic Agents; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cinnamates; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2013 |
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Caffeic Acids; Coumaric Acids; Masoprocol; Phenylethyl Alcohol; Prealbumin; Propolis | 2014 |
Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Lipoxygenase Inhibitors; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2016 |
Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.
Topics: Animals; Benzophenones; Blood-Brain Barrier; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Survival; Dose-Response Relationship, Drug; Hepatocytes; Male; Models, Molecular; Molecular Structure; Nitriles; Nitrophenols; Rats; Rats, Wistar; Structure-Activity Relationship; Tolcapone | 2016 |
Caffeic Acid Phenethyl Ester from the Twigs of Cinnamomum cassia Inhibits Malignant Cell Transformation by Inducing c-Fos Degradation.
Topics: Anticarcinogenic Agents; Caffeic Acids; Cinnamomum aromaticum; Molecular Structure; Phenylethyl Alcohol; Plant Stems; Proto-Oncogene Proteins c-fos; Republic of Korea; Signal Transduction; Transcription Factor AP-1 | 2017 |
Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
Topics: Amyloid beta-Peptides; Antioxidants; Cinnamates; Depsides; Dose-Response Relationship, Drug; Humans; Molecular Dynamics Simulation; Molecular Structure; Protein Aggregates; Rosmarinic Acid; Structure-Activity Relationship | 2017 |
Repurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6.
Topics: Caffeic Acids; Catechols; Chelating Agents; Copper; Drug Design; Nitro Compounds; Peptides; Phenylethyl Alcohol; Polyphenols; Protein Aggregation, Pathological; Small Molecule Libraries; tau Proteins; Tauopathies | 2019 |
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
Topics: Angiogenesis Inhibitors; Apoptosis; Caffeic Acids; Cell Line, Tumor; Down-Regulation; Genes, myc; Humans; Ikaros Transcription Factor; Interferon Regulatory Factors; Lenalidomide; Multiple Myeloma; Phenylethyl Alcohol; Sp1 Transcription Factor; Structure-Activity Relationship | 2020 |
Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.
Topics: Antioxidants; Caffeic Acids; Hordeum; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Lipoxygenase Inhibitors; Luminescent Measurements; Neutrophils; Oxidation-Reduction; Phenylethyl Alcohol; Reactive Oxygen Species; Xanthine; Xanthine Oxidase; Xanthines | 1993 |
The effect of propolis and its components on eicosanoid production during the inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arachidonic Acid; Caffeic Acids; Cyclooxygenase Inhibitors; Diet; Eicosanoids; Flavanones; Flavonoids; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Masoprocol; Mice; Mice, Inbred C57BL; Peritoneal Cavity; Phenylethyl Alcohol; Propolis; Quercetin; Urea; Zymosan | 1996 |
Effect of quercetin, caffeic acid and caffeic acid phenylethyl ester, solubilized in non-ionic surfactants, on histamine release in vivo and in vitro.
Topics: Animals; Antioxidants; Caffeic Acids; Cytotoxins; Histamine; Histamine Release; In Vitro Techniques; Mast Cells; Phenylethyl Alcohol; Quercetin; Rats; Rats, Wistar; Surface-Active Agents | 2000 |
Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity.
Topics: Animals; Caffeic Acids; Cell Line; Cytotoxins; DNA Primers; Gene Expression Regulation; Interferon-gamma; Kinetics; Lipopolysaccharides; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylethyl Alcohol; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2002 |
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Metastasis; NF-kappa B; Phenylethyl Alcohol; Transcription, Genetic | 2004 |
In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis.
Topics: Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Depsides; Drug Stability; Humans; Hydrolysis; Phenylethyl Alcohol; Propolis; Rats; Rosmarinic Acid | 2007 |
Caffeic acid phenethyl ester and its related compounds limit the functional alterations of the isolated mouse brain and liver mitochondria submitted to in vitro anoxia-reoxygenation: relationship to their antioxidant activities.
Topics: Anaerobiosis; Animals; Anisotropy; Antioxidants; Brain; Caffeic Acids; Coumaric Acids; Cytochromes c; Dose-Response Relationship, Drug; Male; Mice; Mitochondria; Mitochondria, Liver; Mitochondrial Membranes; Molecular Structure; Oxygen; Phenylethyl Alcohol; Thiobarbituric Acid Reactive Substances | 2008 |
Cytoprotection of human endothelial cells from menadione cytotoxicity by caffeic acid phenethyl ester: the role of heme oxygenase-1.
Topics: Antioxidants; Blotting, Western; Caffeic Acids; Carbon Monoxide; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Heme Oxygenase-1; Humans; Oxidative Stress; Phenylethyl Alcohol; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Up-Regulation; Vitamin K 3 | 2008 |
Simultaneous determination of caffeic acid phenethyl ester and its metabolite caffeic acid in dog plasma using liquid chromatography tandem mass spectrometry.
Topics: Animals; Caffeic Acids; Chemical Precipitation; Chromatography, Liquid; Dogs; Drug Stability; Phenylethyl Alcohol; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.
Topics: Acrolein; ADAM Proteins; ADAM10 Protein; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Caffeic Acids; Cell Line; Cell Survival; Glutathione; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; MAP Kinase Signaling System; Membrane Proteins; Mice; Neurons; Neuroprotective Agents; Oxidative Stress; Phenylethyl Alcohol; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2013 |
A novel continuous flow biosynthesis of caffeic acid phenethyl ester from alkyl caffeate and phenethanol in a packed bed microreactor.
Topics: Bioreactors; Caffeic Acids; Chromatography, High Pressure Liquid; Ethanol; Kinetics; Phenylethyl Alcohol; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization | 2014 |
Migration Rate Inhibition of Breast Cancer Cells Treated by Caffeic Acid and Caffeic Acid Phenethyl Ester: An In Vitro Comparison Study.
Topics: Breast Neoplasms; Caffeic Acids; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Humans; Mitochondria; Phenylethyl Alcohol; Propolis | 2017 |
Marker-based standardization and investigation of nutraceutical potential of Indian propolis.
Topics: Animals; Antioxidants; Bees; Caffeic Acids; Chromatography, High Pressure Liquid; Dietary Supplements; Ethanol; Flavanones; Flavonoids; Humans; India; Nutritive Value; Phenylethyl Alcohol; Plant Extracts; Polyphenols; Propolis | 2017 |
Aspergillus niger whole-cell catalyzed synthesis of caffeic acid phenethyl ester in ionic liquids.
Topics: Alcohols; Aspergillus niger; Biocatalysis; Bioreactors; Caffeic Acids; Esterification; Fungal Proteins; Ionic Liquids; Kinetics; Lipase; Phenylethyl Alcohol; Solubility; Temperature | 2018 |
Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition.
Topics: Breast Neoplasms; Caffeic Acids; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; MCF-7 Cells; Phenylethyl Alcohol | 2018 |
Synthesis of Diverse Hydroxycinnamoyl Phenylethanoid Esters Using Escherichia coli.
Topics: Caffeic Acids; Coumaric Acids; Escherichia coli; Esterification; Esters; Glucose; Mannosyltransferases; Oryza; Phenylethyl Alcohol; Transformation, Bacterial | 2019 |
Inhibition of Human Cathepsins B and L by Caffeic Acid and Its Derivatives.
Topics: Caffeic Acids; Cathepsin B; Cathepsin L; Chlorogenic Acid; Drug Discovery; Enzyme Inhibitors; Humans; Phenylethyl Alcohol; Proteolysis | 2020 |
Interaction between caffeic acid/caffeic acid phenethyl ester and micellar casein.
Topics: Antioxidants; Caffeic Acids; Caseins; Hydrophobic and Hydrophilic Interactions; Micelles; Phenylethyl Alcohol; Protein Binding; Protein Structure, Secondary; Solubility | 2021 |
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Animals; Bees; Caffeic Acids; COVID-19 Drug Treatment; Flavanones; Flavonoids; Hesperidin; Humans; Luteolin; Molecular Docking Simulation; Phenylethyl Alcohol; Plant Extracts; Propolis; Quercetin; Rutin | 2021 |
Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Topics: Animals; Anti-Allergic Agents; beta-N-Acetylhexosaminidases; Caffeic Acids; Cell Degranulation; Humans; Hypersensitivity; Mast Cells; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Nerve Tissue Proteins; p-Methoxy-N-methylphenethylamine; Phenylethyl Alcohol; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Secretagogues | 2022 |
Molecular Mechanisms of Oxidative Stress Relief by CAPE in ARPE-19 Cells.
Topics: Antioxidants; Apoptosis; Caffeic Acids; Humans; Oxidative Stress; Phenylethyl Alcohol; Reactive Oxygen Species | 2023 |
Effects of Temperature, Metal Ions and Biosurfactants on Interaction Mechanism between Caffeic Acid Phenethyl Ester and Hemoglobin.
Topics: Caffeic Acids; Hemoglobins; Molecular Docking Simulation; Phenylethyl Alcohol; Temperature | 2023 |
Investigation into Propolis Components Responsible for Inducing Skin Allergy: Air Oxidation of Caffeic Acid and Its Esters Contribute to Hapten Formation.
Topics: Cysteine; Esters; Haptens; Humans; Hypersensitivity; Phenylethyl Alcohol; Propolis | 2023 |
Intralipid and caffeic acid phenethyl ester reverse the neurotoxic effects of organophosphate poisoning in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Organophosphate Poisoning; Organophosphates; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2023 |